NCT02332551View on ClinicalTrials.gov

Percutaneous Irreversible Electroporation to Treat Liver Cancer Close to the Gallbladder

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

December 1, 2020

Study Completion Date

August 1, 2021

Conditions
Hepatic Carcinoma
Interventions
DEVICE

NanoKnife

Irreversible electroporation (IRE) is a new, minima-invasive image-guided treatment method for tumors not amenable for surgical resection or thermal ablation, due to vicinity near vital structures such as vessels,bile ducts and the gallbladder .

Trial Locations (1)

510665

中国, Guangzhou

All Listed Sponsors
lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT02332551 - Percutaneous Irreversible Electroporation to Treat Liver Cancer Close to the Gallbladder | Biotech Hunter | Biotech Hunter